Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Armistice Capital, LLC's stake in Agios Pharmaceuticals, Inc. fell to 4.57% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Armistice Capital, LLC's stake in Agios Pharmaceuticals, Inc. fell to 4.57%, 2,716,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.57%
- Shares
- 2,716,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.57% | 2,716,000 |
| Steven Boyd | 4.57% | 2,716,000 |
Source
Related
- Agios Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · Feb 17, 2026
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026